The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
暂无分享,去创建一个
J. Crowley | Kenji Suzuki | R. Rami-Porta | W. Travis | Yi-long Wu | V. Bolejack | T. Rice | Jhingook Kim | D. Ball | G. Lyons | C. Thomas | Yi-Long Wu
[1] Bronchogenic. Clinical tumour size and prognosis in lung cancer. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). , 1999, The European respiratory journal.
[2] Kenji Suzuki,et al. The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[3] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[4] J. Pignon,et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] E. Miyaoka,et al. How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations. , 2006, The Journal of thoracic and cardiovascular surgery.
[6] D. Ornstein. TNM Supplement: A Commentary on Uniform Use 2nd ed. , 2002 .
[7] H. Libshitz,et al. Patterns of mediastinal metastases in bronchogenic carcinoma. , 1986, Chest.
[8] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Data Elements for the Prospective Project , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[9] J. V. van Meerbeeck,et al. Determination of the molecular relationship between multiple tumors within one patient is of clinical importance. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] V. Rusch,et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. , 2003, The Journal of thoracic and cardiovascular surgery.
[11] R. Rami-Porta,et al. Staging in lung cancer: is 3 cm a prognostic threshold in pathologic stage I non-small cell lung cancer? A multicenter study of 1,020 patients. , 2002, Chest.
[12] Richard A. Szucs,et al. TNM Classification of Malignant Tumors. 5th ed , 1998 .
[13] F. Petrella,et al. Outcome and prognostic factors of resected non-small-cell lung cancer invading the diaphragm. , 2013, Interactive cardiovascular and thoracic surgery.
[14] J. Furák,et al. Lung cancer and its operable brain metastasis: survival rate and staging problems. , 2005, The Annals of thoracic surgery.
[15] D. Miller,et al. Results of surgical resection in patients with N2 non-small cell lung cancer. , 1994, The Annals of thoracic surgery.
[16] N. Tsubota,et al. Skip metastasis and hidden N2 disease in lung cancer: How successful is mediastinal dissection? , 1996, Surgery Today.
[17] E. Miyaoka,et al. Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival: Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[18] K. Athanassiadi,et al. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[19] John Crowley,et al. Some Exploratory Tools for Survival Analysis , 1997 .
[20] M. Okada,et al. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. , 1998, The Journal of thoracic and cardiovascular surgery.
[21] A. Sakurada,et al. Five‐year survivors with resected PN2 nonsmall cell lung carcinoma , 1999, Cancer.
[22] J. Verschakelen,et al. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer , 2007, European Respiratory Journal.
[23] H. D. de Koning,et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. , 2013, American journal of respiratory and critical care medicine.
[24] R. Tsuchiya,et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. , 2001, The Annals of thoracic surgery.
[25] M. Riquet,et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. , 2001, Chest.
[26] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[27] C. Sima,et al. Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma. , 2013, Chest.
[28] X. Bonfill,et al. Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer. , 2006, The Cochrane database of systematic reviews.
[29] T. Naruke,et al. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. , 1978, The Journal of thoracic and cardiovascular surgery.
[30] Y. Ichinose,et al. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. , 1996, The Annals of thoracic surgery.
[31] J. Lammers,et al. p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma , 2002, Cancer.
[32] M. Haniuda,et al. [Assessment of the new TNM classification for resected lung cancer]. , 2000, Kyobu geka. The Japanese journal of thoracic surgery.
[33] H. Groen,et al. Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[35] K. Yasumoto,et al. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. , 1999, Chest.
[36] Bonny R. Hart,et al. Prognostic significance of N1 disease in carcinoma of the lung. , 1983, The Journal of thoracic and cardiovascular surgery.
[37] J. Crowley,et al. Should the 7th Edition of the Lung Cancer Stage Classification System Change Treatment Algorithms in Non-small Cell Lung Cancer? , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[38] C. Gutschow,et al. Role of skip metastasis to mediastinal lymph nodes in non‐small cell lung cancer , 2003, Journal of surgical oncology.
[39] A. Perruchoud,et al. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning. , 1991, Thorax.
[40] T. de Giacomo,et al. Prognostic factors after surgical treatment of lung cancer invading the diaphragm. , 1999, The Annals of thoracic surgery.
[41] H. Asamura,et al. Where is the boundary between N1 and N2 stations in lung cancer? , 2000, The Annals of thoracic surgery.
[42] S. Yamazaki,et al. [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer]. , 2000, Kyobu geka. The Japanese journal of thoracic surgery.
[43] P. Goldstraw. The International Staging Committee of the IASLC: Its origins and purpose , 2002 .
[44] H. Li,et al. Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma. , 1999, The Annals of thoracic surgery.
[45] D. Skinner,et al. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer , 1986 .
[46] A. Dujon,et al. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. , 1999, The Annals of thoracic surgery.
[47] G. Bepler,et al. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[49] J. Vansteenkiste,et al. Practical approach to patients presenting with multiple synchronous suspect lung lesions: a reflection on the current TNM classification based on 54 cases with complete follow-up. , 2001, Lung cancer.
[50] G. Darling,et al. Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set. , 2012, Lung cancer.
[51] A. Marrogi,et al. Lung cancer staging: a case for a new T definition. , 2006, The Annals of thoracic surgery.
[52] A. Marra,et al. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. , 2003, The Journal of thoracic and cardiovascular surgery.
[53] M. Tsuboi,et al. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. , 2001, The Journal of thoracic and cardiovascular surgery.
[54] J. Lammers,et al. Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma. , 1999, The Annals of thoracic surgery.
[55] Y. Ohno,et al. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. , 2004, The Journal of thoracic and cardiovascular surgery.
[56] K. Nackaerts,et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases , 1997 .
[57] E. Miyaoka,et al. Visceral Pleural Invasion Classification in Non–Small-Cell Lung Cancer in the 7th Edition of the Tumor, Node, Metastasis Classification for Lung Cancer: Validation Analysis Based on a Large-Scale Nationwide Database , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[58] P. Goldstraw. Report on the international workshop on intrathoracic staging. London, October 1996 , 1997 .
[59] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[60] P. Hudgins,et al. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. , 1991, AJNR. American journal of neuroradiology.
[61] K. Nagai,et al. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification. , 2011, Chest.
[62] I sabel Mortara,et al. International Union against Cancer , 1938, Nature.
[63] T. Araki,et al. Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.
[64] R. Snijder,et al. Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastases. , 1996, Chest.
[65] M. Riquet,et al. Results of surgical treatment of lung cancer involving the diaphragm. , 2001, The Journal of thoracic and cardiovascular surgery.
[66] Kenji Suzuki,et al. Intrapulmonary metastasis of non-small cell lung cancer: a prognostic assessment. , 2001, The Journal of thoracic and cardiovascular surgery.
[67] N. Martini. Mediastinal lymph node dissection for lung cancer. The Memorial experience. , 1995, Chest surgery clinics of North America.
[68] Robert D Timmerman,et al. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. , 2006, Seminars in radiation oncology.
[69] M. Terashima,et al. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer. , 1997, The Journal of thoracic and cardiovascular surgery.
[70] C. Mountain,et al. Regional lymph node classification for lung cancer staging. , 1997, Chest.
[71] E. Miyaoka,et al. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer. , 2001, The Journal of thoracic and cardiovascular surgery.
[72] J. Crowley,et al. The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[73] J. Crowley,et al. The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer , 2006 .
[74] Akihiko Yoshizawa,et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases , 2011, Modern Pathology.
[75] V. Calvo,et al. Resección de carcinoma broncogénico con invasión diafragmática , 1999 .
[76] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[77] J. Padilla,et al. Surgical results and prognostic factors in early non-small cell lung cancer. , 1997, The Annals of thoracic surgery.
[78] M. Okada,et al. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. , 2012, The Journal of thoracic and cardiovascular surgery.
[79] E. Rosenow,et al. Evaluation and management of solitary and multiple pulmonary nodules. , 1992, Clinics in chest medicine.
[80] R. Tsuchiya,et al. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. , 1999, The Journal of thoracic and cardiovascular surgery.
[81] H. Dienemann,et al. Adrenalectomy for solitary adrenal metastases from non-small cell lung cancer. , 2005, Lung cancer.
[82] Tao-Sheng Li,et al. Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer. , 2003, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.
[83] P. Goldstraw. Staging manual in thoracic oncology , 2009 .
[84] O. Miettinen,et al. Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.
[85] J. Padilla,et al. [Resection of bronchogenic carcinoma invading the diaphragm]. , 1999, Archivos de bronconeumologia.
[86] E. Ruffini,et al. Resection and radical lymphadenectomy for lung cancer: prognostic significance of lymphatic metastases. , 1990, International surgery.
[87] G. Watanabe,et al. Results of initial operations in non-small cell lung cancer patients with single-level N2 disease. , 2006, The Annals of thoracic surgery.
[88] M. Vangel,et al. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. , 2004, The Journal of thoracic and cardiovascular surgery.
[89] D. Boffa,et al. Reacting to Changes in Staging Designations in the 7th Edition of the AJCC Staging Manual , 2010, Annals of Surgical Oncology.
[90] S. Takeda,et al. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. , 2005, The Annals of thoracic surgery.
[91] P. Goldstraw,et al. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). , 1994, The Journal of thoracic and cardiovascular surgery.
[92] H. Horinouchi,et al. [Surgical indications for lung cancer: influence of the M factor]. , 2001, Nihon Geka Gakkai zasshi.
[93] M. Okada,et al. Prognosis of completely resected pN2 non-small cell lung carcinomas: What is the significant node that affects survival? , 1999, The Journal of thoracic and cardiovascular surgery.
[94] R. Rami-Porta,et al. Strength and weakness of the new TNM classification for lung cancer , 2010, European Respiratory Journal.
[95] Y. Ichinose,et al. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. , 1994, The Journal of thoracic and cardiovascular surgery.
[96] R. Rami-Porta,et al. Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the Staging Project Database of the International Association for the Study of Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[97] V. Rusch,et al. Visceral Pleural Invasion: Pathologic Criteria and Use of Elastic Stains: Proposal for the 7th Edition of the TNM Classification for Lung Cancer , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[98] V. Rusch,et al. Survival after resection of stage II non-small cell lung cancer. , 1992, The Annals of thoracic surgery.
[99] A. Dujon,et al. Factors determining survival in resected N2 lung cancer. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[100] J. Usuda,et al. Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer. , 2012, Lung cancer.
[101] R. Snijder,et al. Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma. , 1997, The Annals of thoracic surgery.
[102] P. Zanen,et al. Survival in synchronous vs. single lung cancer: upstaging better reflects prognosis. , 2000, Chest.